KLF10 has been indicated as a marker for breast cancer, and different stages of breast tumor tissues from different populations show decreased mRNA levels of KLF10, Smad2, and BRAD1 (breast cancer 1 associated RING domain 1), while Smad7 is inversely correlated with KLF10 [73]. This evidence concerns the gene KLF10 and breast neoplasm.